Dynamic Profiling of Antitumor Activity of CAR T Cells Using Micropatterned Tumor Arrays

Xiao Wang1,2,3, Irene Scarfò3,4, Andrea Schmidts3,4

  • 1BioMEMS Resource Center Department of Surgery Massachusetts General Hospital Boston MA 02114 USA.

Insights

A new micropatterned tumor array (MiTA) precisely measures chimeric antigen receptor (CAR) T cell trafficking and killing. This tool reveals CAR T cell clustering enhances tumor cell destruction, aiding immunotherapy development.

Area of Science:

  • Immunology
  • Oncology
  • Biotechnology

Background:

  • Chimeric antigen receptor (CAR) T cell therapy shows promise for B-cell malignancies.
  • Accurate preclinical assessment of CAR T cell functions (trafficking, cytotoxicity) is crucial for therapeutic development.
  • Existing tools for evaluating CAR T cell function lack precision.

Purpose of the Study:

  • To introduce a novel micropatterned tumor array (MiTA) for detailed CAR T cell function analysis.
  • To dynamically characterize CAR T cell trafficking and tumor cell killing.
  • To enable high-content evaluation of CAR T cell-mediated immunotherapy.

Main Methods:

  • Development and application of a micropatterned tumor array (MiTA).
  • Dynamic monitoring of CAR T cell migration towards tumor cell islands.
  • Quantification of tumor cell killing and CAR T cell clustering behavior.

Main Results:

  • MiTA enables detailed, dynamic characterization of CAR T cell trafficking and cytotoxicity.
  • CAR T cells form clusters that efficiently envelop and kill tumor cells.
  • Significant variations in CAR T cell performance were observed between donors and constructs.

Conclusions:

  • The MiTA assay provides multifaceted, high-content evaluation of CAR T cell functions.
  • This tool can advance immune-oncology research and preclinical assessment of cell-based immunotherapies.
  • MiTA offers a more precise method for understanding CAR T cell efficacy.

Related Concept Videos